KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Gilead Sciences (GILD) Assets Average (2016 - 2025)

Historic Assets Average for Gilead Sciences (GILD) over the last 17 years, with Q3 2025 value amounting to $57.1 billion.

  • Gilead Sciences' Assets Average rose 568.9% to $57.1 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $57.1 billion, marking a year-over-year increase of 568.9%. This contributed to the annual value of $60.6 billion for FY2024, which is 333.29% down from last year.
  • Per Gilead Sciences' latest filing, its Assets Average stood at $57.1 billion for Q3 2025, which was up 568.9% from $56.1 billion recorded in Q2 2025.
  • Gilead Sciences' Assets Average's 5-year high stood at $67.9 billion during Q1 2021, with a 5-year trough of $54.1 billion in Q3 2024.
  • In the last 5 years, Gilead Sciences' Assets Average had a median value of $62.4 billion in 2023 and averaged $61.6 billion.
  • Its Assets Average has fluctuated over the past 5 years, first soared by 1711.78% in 2021, then tumbled by 1331.57% in 2024.
  • Quarter analysis of 5 years shows Gilead Sciences' Assets Average stood at $67.5 billion in 2021, then dropped by 6.9% to $62.9 billion in 2022, then decreased by 0.98% to $62.2 billion in 2023, then decreased by 8.82% to $56.8 billion in 2024, then increased by 0.65% to $57.1 billion in 2025.
  • Its last three reported values are $57.1 billion in Q3 2025, $56.1 billion for Q2 2025, and $57.7 billion during Q1 2025.